Description:
The hydrochloride salt form of VU0357017 which is a selective M1 agonist and has been found to be probably effective in the treatment of hippocampal-dependent cognitive function deficits. EC50 = 477 ± 172 nM.
- Molecular Weight:369.89
- Purity:>98%
Molecular Formula:
C18H27N3O3.HCl
Canonical SMILES:
CCOC(=O)N1CCC(CC1)NCCNC(=O)C2=CC=CC=C2C.Cl
InChI:
InChI=1S/C18H27N3O3.ClH/c1-3-24-18(23)21-12-8-15(9-13-21)19-10-11-20-17(22)16-7-5-4-6-14(16)2;/h4-7,15,19H,3,8-13H2,1-2H3,(H,20,22);1H
InChIKey:
XKJQVUIXSBOCPP-UHFFFAOYSA-N
Solubility:
DMSO: ≥ 33 mg/mL
Appearance:
Powder
Storage: -20ºC Freeze
Synonyms:
VU0357017; VU-0357017; VU 0357017; CID 25010775; CID25010775; CID-25010775; 4-[[2-[(2-Methylbenzoyl)amino]ethyl]amino]-1-piperidinecarboxylic Acid Ethyl Ester Hydrochloride Weitere Informationen finden Sie
hier